Molecular Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Front Immunol. 2023 Jun 15;14:1179846. doi: 10.3389/fimmu.2023.1179846. eCollection 2023.
Peptide loading of MHC-I molecules plays a critical role in the T cell response to infections and tumors as well as to interactions with inhibitory receptors on natural killer (NK) cells. To facilitate and optimize peptide acquisition, vertebrates have evolved specialized chaperones to stabilize MHC-I molecules during their biosynthesis and to catalyze peptide exchange favoring high affinity or optimal peptides to permit transport to the cell surface where stable peptide/MHC-I (pMHC-I) complexes are displayed and are available for interaction with T cell receptors and any of a host of inhibitory and activating receptors. Although components of the endoplasmic reticulum (ER) resident peptide loading complex (PLC) were identified some 30 years ago, the detailed biophysical parameters that govern peptide selection, binding, and surface display have recently been understood better with advances in structural methods including X-ray crystallography, cryogenic electron microscopy (cryo-EM), and computational modeling. These approaches have provided refined mechanistic illustration of the molecular events involved in the folding of the MHC-I heavy chain, its coordinate glycosylation, assembly with its light chain, β-microglobulin (βm), its association with the PLC, and its binding of peptides. Our current view of this important cellular process as it relates to antigen presentation to CD8 T cells is based on many different approaches: biochemical, genetic, structural, computational, cell biological, and immunological. In this review, taking advantage of recent X-ray and cryo-EM structural evidence and molecular dynamics simulations, examined in the context of past experiments, we attempt a dispassionate evaluation of the details of peptide loading in the MHC-I pathway. By critical evaluation of several decades of investigation, we outline aspects of the peptide loading process that are well-understood and indicate those that demand further detailed investigation. Further studies should contribute not only to basic understanding, but also to applications for immunization and therapy of tumors and infections.
肽负载在 MHC-I 分子上对于 T 细胞对感染和肿瘤的反应以及与自然杀伤 (NK) 细胞上的抑制性受体的相互作用至关重要。为了促进和优化肽的获取,脊椎动物进化出了专门的伴侣分子,以在 MHC-I 分子的生物合成过程中稳定它们,并催化有利于高亲和力或最佳肽的肽交换,从而允许其转运到细胞表面,在那里稳定的肽/MHC-I (pMHC-I) 复合物被展示,并可与 T 细胞受体和宿主的许多抑制性和激活性受体相互作用。尽管内质网 (ER) 驻留肽加载复合物 (PLC) 的成分在大约 30 年前就被鉴定出来,但随着结构方法的进步,包括 X 射线晶体学、低温电子显微镜 (cryo-EM) 和计算建模,最近对控制肽选择、结合和表面展示的详细生物物理参数有了更好的理解。这些方法提供了对 MHC-I 重链折叠、其协调糖基化、与轻链、β2-微球蛋白 (βm) 组装、与 PLC 结合以及与肽结合的分子事件的精细机制说明。我们目前对这一重要细胞过程的看法是基于许多不同的方法:生化、遗传、结构、计算、细胞生物学和免疫学。在这篇综述中,我们利用最近的 X 射线和 cryo-EM 结构证据和分子动力学模拟,并结合过去的实验,对 MHC-I 途径中肽负载的细节进行了客观评估。通过对几十年来的研究进行批判性评价,我们概述了肽负载过程中理解较好的方面,并指出了那些需要进一步详细研究的方面。进一步的研究不仅应该有助于基础理解,而且应该有助于肿瘤和感染的免疫接种和治疗的应用。